Literature DB >> 22216505

Factors influencing the absorption and disposition of mecillinam and pivmecillinam in man.

J Andrews1, M J Kendall, M Mitchard.   

Abstract

In a pharmacokinetic study in six volunteers peak serum mecillinam concentrations were proportional to the oral dose of pivmecillinam at two dose levels of 200 and 400 mg. Effects of bed rest, probenecid and a 6 day course of treatment with pivmecillinam on serum mecillinam concentrations after an oral dose of pivmecillinam (two 200 mg capsules) have been investigated. Resting subjects had lower peak serum levels and a decreased rate of clearance than moderately active subjects, changes which are similar to those previously reported for benzylpenicillin. Pretreatment with probenecid produced significantly higher serum mecillinam levels, a longer serum antibiotic half-life and a decreased rate of drug clearance which suggests that mecillinam is actively excreted by kidney tubules. Plasma mecillinam level profiles obtained after the first dose of a 6 day treatment period were not significantly different from corresponding values after the first dose on the seventh day which indicates that each dose of mecillinam is eliminated in healthy young adults before succeeding doses are taken.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 22216505      PMCID: PMC1428919          DOI: 10.1111/j.1365-2125.1976.tb04886.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Bacteriology and pharmacokinetics of the new amidino penicillin-mecillinam.

Authors:  J D Williams; J Andrews; M Mitchard; M J Kendall
Journal:  J Antimicrob Chemother       Date:  1976-03       Impact factor: 5.790

2.  Empirical equation for pharmacokinetic analysis of drug serum levels after oral application.

Authors:  H Engberg-Pedersen
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

3.  Activity of FL 1060, a new beta-lactam antibiotic, against urinary tract pathogens.

Authors:  D Greenwood; H L Brooks; R Gargan; F O'Grady
Journal:  J Clin Pathol       Date:  1974-03       Impact factor: 3.411

4.  FL-1060: a new penicillin with a unique mode of action.

Authors:  J T Park; L Burman
Journal:  Biochem Biophys Res Commun       Date:  1973-04-16       Impact factor: 3.575

5.  6 -amidinopenicillanic acids--a new group of antibiotics.

Authors:  F Lund; L Tybring
Journal:  Nat New Biol       Date:  1972-04-05

6.  Clinical pharmacology of pivampicillin as compared with ampicillin.

Authors:  M C Jordan; J B de Maine; W M Kirby
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

7.  Effect of bed rest on distribution and elimination of drugs.

Authors:  G Levy
Journal:  J Pharm Sci       Date:  1967-07       Impact factor: 3.534

8.  Pharmacokinetic studies with mecillinam and pivmecillinam.

Authors:  K Roholt; B Nielsen
Journal:  Chemotherapy       Date:  1975       Impact factor: 2.544

  8 in total
  3 in total

1.  Pharmacokinetics of bacmecillinam and pivmecillinam in volunteers.

Authors:  K Josefsson; T Bergan; L Magni; B G Pring; D Westerlund
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

2.  Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.

Authors:  Fardod O'Kelly; Siobhan Kavanagh; Rustom Manecksha; John Thornhill; Jérôme P Fennell
Journal:  BMC Infect Dis       Date:  2016-11-03       Impact factor: 3.090

Review 3.  Physiological adaptations affecting drug pharmacokinetics in space: what do we really know? A critical review of the literature.

Authors:  Cinzia Dello Russo; Tiziano Bandiera; Monica Monici; Leonardo Surdo; Vincent Lai Ming Yip; Virginia Wotring; Lucia Morbidelli
Journal:  Br J Pharmacol       Date:  2022-03-15       Impact factor: 9.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.